KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $59,000 | -68.6% | 13,137 | -27.9% | 0.01% | -72.2% |
| Q2 2021 | $188,000 | -62.0% | 18,229 | -61.3% | 0.02% | -48.6% |
| Q1 2021 | $495,000 | -36.1% | 47,054 | -6.1% | 0.04% | -58.3% |
| Q4 2020 | $775,000 | +682.8% | 50,086 | +387.8% | 0.08% | +950.0% |
| Q3 2019 | $99,000 | -49.2% | 10,267 | -10.5% | 0.01% | -33.3% |
| Q3 2018 | $195,000 | -41.3% | 11,466 | -53.6% | 0.01% | -33.3% |
| Q1 2018 | $332,000 | +65.2% | 24,710 | +35.1% | 0.02% | +80.0% |
| Q3 2017 | $201,000 | – | 18,293 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |